Immunomodulating IL-6 activity by murine monoclonal antibodies
- 31 January 1995
- journal article
- clinical trial
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 17 (1) , 41-48
- https://doi.org/10.1016/0192-0561(94)00076-z
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myelomaBlood, 1994
- Interleukin-6 dependence of advanced malignant plasma cell dyscrasiasCancer, 1992
- Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemiaBlood, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989
- Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomasNature, 1988
- The Human Immune Response to the OKT3 Monoclonal Antibody Is OligoclonalScience, 1986
- Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibodyEuropean Journal of Immunology, 1982
- Serotherapy of acute lymphoblastic leukemia with monoclonal antibodyBlood, 1981
- Antibody Formation in MyelomatosisJournal of Clinical Pathology, 1953